Analysis of 3′-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 1, 2010, Pages 172-177

  Shokrzadeh, Leila ^a   Baghaei, Kaveh ^a   Yamaoka, Yoshio ^b,c   Dabiri, Hossein ^a   Jafari, Fereshteh ^a   Sahebekhtiari, Navid ^a   Tahami, Ali ^a   Sugimoto, Mitsushige ^b   Zojaji, Homayon ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c OITA UNIVERSITY   (Japan)

Author keywords

CagA; Helicobacter pylori; Pathogenesis; Repeat region; Virulence factors

Indexed keywords

CAGA PROTEIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BACTERIUM ISOLATION; COLOMBIA; CONTROLLED STUDY; DYSPEPSIA; FEMALE; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENOTYPE; HELICOBACTER PYLORI; HUMAN; IRAN; ITALY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER; ASIAN; CHEMISTRY; DNA SEQUENCE; ETHNOLOGY; GENETICS; HELICOBACTER INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PATHOGENICITY; PHENOTYPE; PROTEIN MOTIF; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STOMACH TUMOR; STOMACH ULCER;

ADULT; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIAL PROTEINS; DYSPEPSIA; FEMALE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, PROTEIN; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 73449093843     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05979.x     Document Type: Article

References (40)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N. Engl. J. Med. 2002 347 : 1175 1186.
2. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001 345 : 784 789.
3. Atherton JC, Cao P, Peek RM Jr. et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 1995 270 : 17771 17777.
4. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J. Clin. Microbiol. 1998 36 : 2258 2263.
5. Yamaoka Y, El-Zimaity HM, Gutierrez O et al. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 1999 117 : 342 349.
6. Censini S, Lange C, Xiang Z et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 1996 93 : 14648 14653.
7. Asahi M, Azuma T, Ito S et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 2000 191 : 593 602.
8. Backert S, Ziska E, Brinkmann V et al. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell. Microbiol. 2000 2 : 155 164.
9. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000 287 : 1497 1500.
10. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad. Sci. USA 1999 96 : 14559 14564.
11. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. USA 2000 97 : 1263 1268.
12. Higashi H, Tsutsumi R, Muto S et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002 295 : 683 686.
13. Judd LM, Alderman BM, Howlett M et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 2004 126 : 196 207.
14. Tebbutt NC, Giraud AS, Inglese M et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 2002 8 : 1089 1097.
15. Yamaoka Y, Osato MS, Sepulveda AR et al. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol. Infect. 2000 124 : 91 6.
16. Yamaoka Y, Orito E, Mizokami M et al. Helicobacter pylori in North and South America before Columbus. FEBS Lett. 2002 517 : 180 184.
17. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 2004 4 : 688 694. (Pubitemid 39215067)
18. Hatakeyama M. The role of Helicobacter pylori CagA in gastric carcinogenesis. Int. J. Hematol. 2006 84 : 301 308.
19. Higashi H, Tsutsumi R, Fujita A et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl Acad. Sci. USA 2002 99 : 14428 14433.
20. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004 127 : 514 523.
21. Naito M, Yamazaki T, Tsutsumi R et al. Influence of EPIY: A-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006 130 : 1181 1190.
22. Azuma T, Yamakawa A, Yamazaki S et al. Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J. Infect. Dis. 2002 186 : 1621 1630.
23. Basso D, Zambon CF, Letley DP et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008 135 : 91 9.
24. Rhead JL, Letley DP, Mohammadi M et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007 133 : 926 936.
25. Kamali-Sarvestani E, Bazargani A, Masoudian M et al. A genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J. Gastroenterol. 2006 12 : 5205 5210.
26. Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H. Helicobacter pylori endemic and gastric disease. Dig. Dis. Sci. 2005 50 : 2075 2080.
27. Mohammadi M, Oghalaie A, Mohajerani N et al. Prevalence of Helicobacter pylori vacuolating cytotoxin and its allelic mosaicism as a predictive marker for Iranian dyspeptic patients. Bull. Soc. Pathol. Exot. 2003 96 : 3 5.
28. Hussein NR, Mohammadi M, Talebkhan Y et al. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J. Clin. Microbiol. 2008 46 : 1774 1779.
29. Salehi Z, Jelodar MH, Rassa M, Ahaki M, Mollasalehi H, Mashayekhi F. Helicobacter pylori cagA status and peptic ulcer disease in Iran. Dig. Dis. Sci. 2009 54 : 608 613.
30. Kauser F, Hussain MA, Ahmed I et al. Comparative genomics of Helicobacter pylori isolates recovered from ulcer disease patients in England. BMC Microbiol. 2005 5 : 32.
31. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 1999 37 : 2274 2279.
32. Argent RH, Zhang Y, Atherton JC. Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR. J. Clin. Microbiol. 2005 43 : 791 795.
33. Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 1993 90 : 5791 5795.
34. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 1993 61 : 1799 1809.
35. Higashi H, Yokoyama K, Fujii Y et al. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J. Biol. Chem. 2005 280 : 23130 23137.
36. Hatakeyama M. Helicobacter pylori CagA - a bacterial intruder conspiring gastric carcinogenesis. Int. J. Cancer 2006 119 : 1217 1223. (Pubitemid 44258793)
37. Baghaei K, Shokrzadeh L, Jafari F et al. Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity island isolated from Iranian patients. Dig. Liver Dis. 2009 (in press).
38. Hsu PI, Hwang IR, Cittelly D et al. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am. J. Gastroenterol. 2002 97 : 2231 2238.
39. Kauser F, Khan AA, Hussain MA et al. The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations. J. Clin. Microbiol. 2004 42 : 5302 5308.
40. Panayotopoulou EG, Sgouras DN, Papadakos K et al. Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates. J. Clin. Microbiol. 2007 45 : 488 495.